EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients.

Fischer-Colbrie, J; Witt, A; Heinzl, H; Speiser, P; Czerwenka, K; Sevelda, P; Zeillinger, R

Fischer-Colbrie, J; Witt, A; Heinzl, H; Speiser, P; Czerwenka, K; Sevelda, P; Zeillinger, R.

Affiliation

Fischer-Colbrie J; Department of Gynecology and Obstetrics, University of Vienna, Austria.

Anticancer Res ; 17(1B): 613-9, 1997.

Article in En | MEDLINE | ID: mdl-9066588

Subject(s)

Adenocarcinoma, Clear Cell/chemistry; Adenocarcinoma, Mucinous/chemistry; Biomarkers, Tumor/analysis; Carcinoma, Endometrioid/chemistry; Cystadenocarcinoma, Serous/chemistry; ErbB Receptors/analysis; Neoplasm Proteins/analysis; Ovarian Neoplasms/chemistry; Receptors, Estrogen/analysis; Receptors, Progesterone/analysis; Adult; Aged; Aged, 80 and over; Female; Humans; Menopause; Middle Aged; Prognosis; Survival Analysis

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Receptors, Progesterone / Receptors, Estrogen / Biomarkers, Tumor / Cystadenocarcinoma, Serous / Carcinoma, Endometrioid / Adenocarcinoma, Clear Cell / Adenocarcinoma, Mucinous / ErbB Receptors / Neoplasm Proteins Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Anticancer Res Year: 1997 Type: Article Affiliation country: Austria

Search on Google

XML

PubMed Links